Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,070.00
-100.00 (-1.62%)
At close: Sep 4, 2026

Wonbiogen Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
37,80435,24430,44029,61526,74817,721
Other Revenue
-0-0-0-0-0-0
37,80435,24430,44029,61526,74817,721
Revenue Growth
18.04%15.78%2.79%10.72%50.94%47.46%
Cost of Revenue
18,24417,47616,20215,46914,32510,173
Gross Profit
19,56017,76914,23814,14612,4237,548
Selling, General & Admin
8,5528,5836,5485,7195,9504,048
Research & Development
831.04723.49838.47504.15492.1584.71
Amortization of Goodwill & Intangibles
61.0257.7955.7668.8267.6663.19
Other Operating Expenses
53.2751.6749.1539.0436.9755.85
Operating Expenses
9,9409,5778,0227,1087,3725,508
Operating Income
9,6208,1926,2167,0385,0502,040
Interest Expense
-51.82-40.26-57.77-116.68-1,274-430.65
Interest & Investment Income
259.32269.44304.07279.71128.2547
Earnings From Equity Investments
-146.62-146.6242.83-60.51--
Currency Exchange Gain (Loss)
206.2746.4150.849.99-44.942.36
Other Non Operating Income (Expenses)
721-163.03-3.03-74.84-4.82-2,436
EBT Excluding Unusual Items
10,6088,1586,6537,1153,855-737.83
Gain (Loss) on Sale of Investments
-249.76-90.5-32.6448.67-200-
Gain (Loss) on Sale of Assets
-125.61-124.47-1.38-7.1311.69-57.7
Asset Writedown
-161.78-161.78-196.65---
Pretax Income
10,0717,7816,4227,1573,667-795.53
Income Tax Expense
1,6501,3221,0841,196394.35-135.74
Earnings From Continuing Operations
8,4216,4595,3395,9613,272-659.78
Minority Interest in Earnings
1.53156.15350.98-463.77-66.38-56.42
Net Income
8,4236,6155,6905,4973,206-716.2
Net Income to Common
8,4236,6155,6905,4973,206-716.2
Net Income Growth
43.86%16.27%3.50%71.46%--
Shares Outstanding (Basic)
777777
Shares Outstanding (Diluted)
777877
Shares Change
-1.64%-0.03%-6.72%5.70%3.58%49.52%
EPS (Basic)
1207.12932.80802.00783.94450.77-104.35
EPS (Diluted)
1207.12932.80802.00725.00445.00-105.00
EPS Growth
46.35%16.31%10.62%62.92%--

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1,4896,5128,2013,189-711.95-1,254
Free Cash Flow Per Share
-213.38918.171156.00419.31-98.94-180.51
Dividend Per Share
---100.00050.000-
Dividend Growth
---100.00%--
Gross Margin
51.74%50.42%46.77%47.77%46.44%42.59%
Operating Margin
25.45%23.24%20.42%23.76%18.88%11.51%
Profit Margin
22.28%18.77%18.69%18.56%11.99%-4.04%
Free Cash Flow Margin
-3.94%18.48%26.94%10.77%-2.66%-7.08%
EBITDA
11,1569,6997,8638,6076,2492,921
EBITDA Margin
29.51%27.52%25.83%29.06%23.36%16.48%
D&A For EBITDA
1,5361,5071,6471,5691,199881.58
EBIT
9,6208,1926,2167,0385,0502,040
EBIT Margin
25.45%23.24%20.42%23.76%18.88%11.51%
Effective Tax Rate
16.38%16.99%16.87%16.71%10.75%-
Advertising Expenses
-1,9391,113881.911,184700.07